These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7582987)

  • 1. Thrombin active site inhibitors.
    Das J; Kimball SD
    Bioorg Med Chem; 1995 Aug; 3(8):999-1007. PubMed ID: 7582987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Research Progress of Direct Thrombin Inhibitors.
    Sun ZG; Yang-Liu ; Zhang JM; Cui SC; Zhang ZG; Zhu HL
    Mini Rev Med Chem; 2020; 20(16):1574-1585. PubMed ID: 31644402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
    Isaacs RC; Solinsky MG; Cutrona KJ; Newton CL; Naylor-Olsen AM; McMasters DR; Krueger JA; Lewis SD; Lucas BJ; Kuo LC; Yan Y; Lynch JJ; Lyle EA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2062-6. PubMed ID: 18291642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structure.
    Hanessian S; Therrien E; van Otterlo WA; Bayrakdarian M; Nilsson I; Fjellström O; Xue Y
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1032-6. PubMed ID: 16290930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic thrombin inhibitors as anticoagulants pharmacological aspects.
    Markwardt F; Hauptmann J
    Adv Exp Med Biol; 1993; 340():143-71. PubMed ID: 8154331
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic low-molecular weight thrombin inhibitors: the ideal antithrombotic drug? An introduction.
    Stürzebecher J; Meier J
    J Enzyme Inhib; 1995; 9(1):1-2. PubMed ID: 8568561
    [No Abstract]   [Full Text] [Related]  

  • 7. Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors.
    Li ML; Ren YJ; Dong MH; Ren WX
    Eur J Med Chem; 2015; 96():122-38. PubMed ID: 25874337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.
    Endreas W; Brüßler J; Vornicescu D; Keusgen M; Bakowsky U; Steinmetzer T
    ChemMedChem; 2016 Feb; 11(3):340-9. PubMed ID: 26662675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin inhibitor design.
    Sanderson PE; Naylor-Olsen AM
    Curr Med Chem; 1998 Aug; 5(4):289-304. PubMed ID: 9668196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From natural to synthetic multisite thrombin inhibitors.
    Lombardi A; De Simone G; Galdiero S; Staiano N; Nastri F; Pavone V
    Biopolymers; 1999; 51(1):19-39. PubMed ID: 10380350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active site-directed thrombin inhibitors--II. Studies related to arginine/guanidine bioisosteres.
    St Laurent DR; Balasubramanian N; Han WT; Trehan A; Federici ME; Meanwell NA; Wright JJ; Seiler SM
    Bioorg Med Chem; 1995 Aug; 3(8):1145-56. PubMed ID: 7582986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin inhibitors as antithrombotic agents: the importance of rapid inhibition.
    Stone SR; Tapparelli C
    J Enzyme Inhib; 1995; 9(1):3-15. PubMed ID: 8568565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling and 3D-QSAR studies on the interaction mechanism of tripeptidyl thrombin inhibitors with human alpha-thrombin.
    Jiang H; Chen K; Tang Y; Chen J; Li Q; Wang Q; Ji R
    J Med Chem; 1997 Sep; 40(19):3085-90. PubMed ID: 9301672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-peptidic phenyl-based thrombin inhibitors: exploring structural requirements of the S1 specificity pocket with amidines.
    Lu T; Tomczuk B; Bone R; Murphy L; Salemme FR; Soll RM
    Bioorg Med Chem Lett; 2000 Jan; 10(1):83-5. PubMed ID: 10636250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin inhibitors with novel P1 binding pocket functionality: free energy of binding analysis.
    Mlinsek G; Oblak M; Hodoscek M; Solmajer T
    J Mol Model; 2007 Jan; 13(1):247-54. PubMed ID: 17013633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes.
    Obst U; Banner DW; Weber L; Diederich F
    Chem Biol; 1997 Apr; 4(4):287-95. PubMed ID: 9195869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector.
    Figueiredo AC; de Sanctis D; Gutiérrez-Gallego R; Cereija TB; Macedo-Ribeiro S; Fuentes-Prior P; Pereira PJ
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):E3649-58. PubMed ID: 23223529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond heparinization: design of highly potent thrombin inhibitors suitable for surface coupling.
    Steinmetzer T; Baum B; Biela A; Klebe G; Nowak G; Bucha E
    ChemMedChem; 2012 Nov; 7(11):1965-73. PubMed ID: 22907907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design and synthesis of novel thrombin inhibitors based on phosphinic peptide mimetics.
    Li M; Lin Z; Johnson ME
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1957-62. PubMed ID: 10450962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of thrombin in complex with S-variegin: insights of a novel mechanism of inhibition and design of tunable thrombin inhibitors.
    Koh CY; Kumar S; Kazimirova M; Nuttall PA; Radhakrishnan UP; Kim S; Jagadeeswaran P; Imamura T; Mizuguchi J; Iwanaga S; Swaminathan K; Kini RM
    PLoS One; 2011; 6(10):e26367. PubMed ID: 22053189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.